Polson Ltd
Incorporated in 1900, Polson Ltd does manufacturing and selling of Synthetic Organic Tanning Substance[1]
- Market Cap ₹ 138 Cr.
- Current Price ₹ 11,500
- High / Low ₹ 14,500 / 10,501
- Stock P/E 27.1
- Book Value ₹ 6,441
- Dividend Yield 0.00 %
- ROCE 6.16 %
- ROE 3.83 %
- Face Value ₹ 50.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -0.72% over past five years.
- Company has a low return on equity of 3.91% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97.00 | 103.27 | 103.94 | 108.28 | 105.77 | 108.94 | 96.70 | 88.61 | 97.53 | 83.86 | 96.39 | 93.28 | 92.54 | |
| 84.67 | 90.89 | 88.84 | 89.17 | 87.22 | 92.74 | 80.11 | 72.97 | 81.97 | 69.58 | 80.50 | 78.27 | 77.91 | |
| Operating Profit | 12.33 | 12.38 | 15.10 | 19.11 | 18.55 | 16.20 | 16.59 | 15.64 | 15.56 | 14.28 | 15.89 | 15.01 | 14.63 |
| OPM % | 12.71% | 11.99% | 14.53% | 17.65% | 17.54% | 14.87% | 17.16% | 17.65% | 15.95% | 17.03% | 16.49% | 16.09% | 15.81% |
| 2.78 | 6.92 | 21.88 | 6.57 | 9.93 | 6.09 | 4.85 | 3.98 | 2.73 | 3.43 | 1.24 | 1.85 | 2.07 | |
| Interest | 7.32 | 7.57 | 8.72 | 6.56 | 6.70 | 6.91 | 6.50 | 5.71 | 4.47 | 5.55 | 4.06 | 3.67 | 3.50 |
| Depreciation | 2.56 | 2.16 | 3.06 | 3.25 | 3.68 | 4.02 | 4.53 | 4.77 | 5.13 | 5.51 | 5.75 | 6.06 | 6.24 |
| Profit before tax | 5.23 | 9.57 | 25.20 | 15.87 | 18.10 | 11.36 | 10.41 | 9.14 | 8.69 | 6.65 | 7.32 | 7.13 | 6.96 |
| Tax % | 45.12% | 31.66% | 35.91% | 34.85% | 39.67% | 12.50% | 31.80% | 6.67% | 28.19% | 27.37% | 28.96% | 26.79% | |
| 2.87 | 6.55 | 16.15 | 10.33 | 10.91 | 9.93 | 7.10 | 8.53 | 6.23 | 4.83 | 5.20 | 5.23 | 5.10 | |
| EPS in Rs | 143.50 | 327.50 | 807.50 | 516.50 | 545.50 | 496.50 | 355.00 | 426.50 | 311.50 | 241.50 | 260.00 | 261.50 | 255.00 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -8% |
| 3 Years: | -8% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 4% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 4% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 |
| Reserves | 38.79 | 45.31 | 61.45 | 69.06 | 80.10 | 90.04 | 95.63 | 104.17 | 110.59 | 115.58 | 121.03 | 126.01 | 128.22 |
| 59.19 | 90.85 | 67.23 | 62.78 | 74.19 | 69.08 | 65.26 | 45.45 | 59.72 | 49.58 | 38.10 | 42.98 | 37.78 | |
| 18.47 | 43.30 | 24.91 | 31.44 | 24.95 | 22.12 | 22.37 | 21.32 | 21.14 | 15.18 | 20.55 | 19.12 | 23.48 | |
| Total Liabilities | 117.05 | 180.06 | 154.19 | 163.88 | 179.84 | 181.84 | 183.86 | 171.54 | 192.05 | 180.94 | 180.28 | 188.71 | 190.08 |
| 29.77 | 83.34 | 85.71 | 84.88 | 94.29 | 97.75 | 105.00 | 109.72 | 118.67 | 115.12 | 118.33 | 121.08 | 122.34 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.96 | 4.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 1.15 | 1.15 | 1.43 | 0.00 | 0.00 |
| 82.32 | 91.76 | 68.48 | 79.00 | 85.55 | 84.09 | 78.86 | 60.83 | 72.23 | 64.67 | 60.52 | 67.63 | 67.74 | |
| Total Assets | 117.05 | 180.06 | 154.19 | 163.88 | 179.84 | 181.84 | 183.86 | 171.54 | 192.05 | 180.94 | 180.28 | 188.71 | 190.08 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.19 | 19.12 | 35.09 | 19.35 | 6.13 | 11.15 | 31.73 | 22.41 | 1.54 | 12.17 | 25.38 | 17.20 | |
| -5.77 | -45.87 | -0.29 | -8.67 | -11.35 | 0.27 | -21.92 | 3.31 | -8.91 | -0.07 | -9.69 | -18.66 | |
| -7.20 | 23.16 | -33.55 | -10.79 | 5.37 | -11.92 | -9.89 | -25.01 | 10.08 | -15.21 | -15.24 | 1.67 | |
| Net Cash Flow | 0.22 | -3.59 | 1.25 | -0.10 | 0.16 | -0.49 | -0.08 | 0.72 | 2.71 | -3.11 | 0.45 | 0.21 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55.58 | 59.48 | 89.72 | 95.67 | 82.37 | 86.64 | 83.87 | 75.17 | 50.64 | 52.67 | 52.98 | 46.37 |
| Inventory Days | 97.42 | 68.25 | 18.30 | 50.26 | 131.51 | 126.27 | 84.58 | 71.96 | 254.06 | 255.70 | 177.87 | 152.43 |
| Days Payable | 72.00 | 79.58 | 74.81 | 93.64 | 97.67 | 82.96 | 99.13 | 134.17 | 109.11 | 51.48 | 90.77 | 86.16 |
| Cash Conversion Cycle | 81.00 | 48.15 | 33.22 | 52.28 | 116.21 | 129.95 | 69.32 | 12.97 | 195.59 | 256.89 | 140.07 | 112.64 |
| Working Capital Days | 56.67 | -46.76 | 16.40 | 10.69 | 33.27 | 56.15 | 17.44 | 17.88 | -14.45 | 23.94 | 14.65 | 30.72 |
| ROCE % | 13.13% | 14.60% | 14.34% | 16.04% | 13.42% | 11.61% | 10.54% | 9.50% | 8.13% | 6.51% | 7.04% | 6.16% |
Documents
Announcements
- Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2025 14 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
14 Nov - Unaudited Q2/H1 results ended 30 Sep 2025: income Rs2,200.42L; quarter PAT Rs122.28L; H1 PAT Rs245.10L.
-
Board Meeting Intimation for Intimation Of Board Meeting
6 Nov - Board meeting on 14 Nov 2025 to approve unaudited financials for quarter/half-year ended 30 Sep 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Oct
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 1 Oct
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is a manufacturer and exporter of natural based vegetable tannin extracts and eco friendly leather chemicals for domestic and export market